ERAN MATALON, M.D.

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Established patient office or other outpatient visit, 40-54 minutes

Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes

Established patient office or other outpatient visit, 30-39 minutes

Established patient office or other outpatient visit, 20-29 minutes

Telephone medical discussion with physician, 11-20 minutes

Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes

Aspiration and/or injection of fluid from large joint

Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage

Heart rhythm review and interpretation of continous external ekg over 8-15 days

Injection of drug or substance under skin or into muscle

Injection, denosumab, 1 mg

Administration of influenza virus vaccine

Administration of pneumococcal vaccine

Injection, triamcinolone acetonide, not otherwise specified, 10 mg